CARDIFF ONCOLOGY, INC.
Profile
Company Names
CARDIFF ONCOLOGY, INC.
TROVAGENE, INC.
TROVAGENE INC.
Addresses
11055 FLINTKOTE AVENUE, SAN DIEGO, CA 92121
11055 FLINTKOTE AVENUE, SUITE B, SAN DIEGO, CA 92121
Phone Numbers
(858) 952-7570
858-952-7570
858-217-4838
858 217 4838
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$38,752,200.00
Number of Funding Rounds:
11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2020-06-16
$13,500,000.00
$13,500,000.00
$0.00
Equity
10
2020-05-26
$2,500,000.00
$2,500,000.00
$0.00
Equity
9
2020-05-12
$810,000.00
$810,000.00
$0.00
Equity
8
2020-03-30
$2,084,000.00
$2,084,000.00
$0.00
Equity
7
2019-10-30
$5,000,000.00
$5,000,000.00
$0.00
Equity
6
2019-08-22
$1,500,000.00
$1,500,000.00
$0.00
Equity
5
2019-05-15
$1,500,000.00
$1,500,000.00
$0.00
Equity
4
2019-04-05
$1,500,000.00
$1,500,000.00
$0.00
Equity
3
2017-07-19
$0.00
$6,547,512.00
$6,547,512.00
2
2012-11-21
$3,760,000.00
$4,420,000.00
$660,000.00
Equity
1
2009-06-10
$6,598,200.00
$6,598,200.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS
ADAMS
DIRECTOR, EXECUTIVE OFFICER
PAUL
BILLINGS
DIRECTOR
JOHN
BRANCACCIO
DIRECTOR
SYNERGY PHARMACEUTICALS, INC.
| SYNERGY PHARMACEUTICALS, INC.
| TROVAGENE INC.
| ORCHESTRA CALIBER CO-INVESTMENT PARTNERS, LLC
| CORBUS PHARMACEUTICALS HOLDINGS, INC.
| SAV ACQUISITION CORP
| SAV HOLDINGS CORP.
| TAMIR BIOTECHNOLOGY, INC.
| CONTRAVIR PHARMACEUTICALS, INC.
| ADGERO BIOPHARMACEUTICALS HOLDINGS, INC.
| RASNA THERAPEUTICS INC.
| TROVAGENE, INC.
| CARDIFF ONCOLOGY, INC.
JOHN
P.
BRANCACCIO
DIRECTOR
ATHENA
COUNTOURIOTIS
DIRECTOR
GARY
JACOB
DIRECTOR
GARY
S.
JACOB
DIRECTOR
RODNEY
MARKIN
DIRECTOR
RODNEY
S.
MARKIN
DIRECTOR
DAVID
ROBBINS
EXECUTIVE OFFICER
PARADIGM SPINE LLC
| ENVIRONMENTAL OPERATING SOLUTIONS INC
| TREVI OPPORTUNITIES ONSHORE FUND LP
| TROVAGENE INC.
| TREVI HEALTH VENTURES LP
| TREVI HEALTH VENTURES II LP
| TREVI OPPORTUNITIES OFFSHORE FUND LTD.
| ALEXIAM OPPORTUNITIES ONSHORE FUND LP
| ALEXIAM OPPORTUNITIES OFFSHORE FUND LTD.
| ASYMMETRIC RETURN CAPITAL LTD.
| TCW EM LOCAL CURRENCY ABSOLUTE RETURN FUND, L.P.
| MONOMOY CREDIT OPPORTUNITIES FUND, L.P.
ANTONIUS
SCHUH
EXECUTIVE OFFICER, DIRECTOR
WILLIAM
WELCH
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-06-16
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-05-26
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-05-12
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-03-30
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-10-30
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-08-22
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-05-15
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-04-05
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
2017-07-19
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
Equity
2012-11-21
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
Equity
2009-06-10

